Rationale: Catecholaminergic polymorphic ventricular tachycardia (CPVT) is caused by a single point mutation in a well-defined region of the cardiac type 2 ryanodine receptor (RyR)2. However, the underlying mechanism by which a single mutation in such a large molecule produces drastic effects on channel function remains unresolved. Objective: Using a knock-in (KI) mouse model with a human CPVT-associated RyR2 mutation (R2474S), we investigated the molecular mechanism by which CPVT is induced by a single point mutation within the RyR2. Methods and Results: The R2474S/؉ KI mice showed no apparent structural or histological abnormalities in the heart, but they showed clear indications of other abnormalities. Bidirectional or polymorphic ventricular tachycardia was induced after exercise on a treadmill. The interaction between the N-terminal (amino acids 1 to 600) and central (amino acids 2000 to 2500) domains of the RyR2 (an intrinsic mechanism to close Ca 2؉ channels) was weakened (domain unzipping). On protein kinase A-mediated phosphorylation of the RyR2, this domain unzipping further increased, resulting in a significant increase in the frequency of spontaneous Ca 2؉ transients. cAMP-induced aberrant Ca 2؉ release events (Ca 2؉ sparks/waves) occurred at much lower sarcoplasmic reticulum Ca 2؉ content as compared to the wild type. Addition of a domain-unzipping peptide, DPc10 (amino acids 2460 to 2495), to the wild type reproduced the aforementioned abnormalities that are characteristic of the R2474S/؉ KI mice. Addition of DPc10 to the (cAMP-treated) KI cardiomyocytes produced no further effect. Conclusions: A single point mutation within the RyR2 sensitizes the channel to agonists and reduces the threshold of luminal [Ca 2؉ ] for activation, primarily mediated by defective interdomain interaction within the RyR2.
T o date, more than 70 cardiac ryanodine receptor (RyR)2 missense mutations have been identified that are linked with 2 inherited forms of sudden cardiac death: catecholaminergic polymorphic ventricular tachycardia (CPVT) 1 and arrhythmogenic right ventricular cardiomyopathy type 2. 1 These mutations cluster in 3 well-defined regions of the RyR2 that correspond to malignant hyperthermia or the central core disease mutable regions, designated as the N-terminal domain (amino acids 1 to 600), central domain (amino acids 2000 to 2500), and the C-terminal transmembrane channel domain of the skeletal muscle-type ryanodine receptor (RyR1). 1 This suggests that the RyR2 shares a common domain-mediated channel regulation mechanism with RyR1. Mutations at different positions in each of these domains result in the nearly identical phenotype of channel dysfunctions such as hyperactivation of the Ca 2ϩ channel and hypersensitization to agonists. To account for these phenomena, Ikemoto et al 2, 3 proposed the so-called "domain switch hypothesis" and stated that in the resting or nonactivated state, the N-terminal domain and the central domain make close contact at several subdomains (domain zipping). Then, on physiological or pharmacological stimulation, these critical interdomain contacts are weakened, resulting in the loss of conformational constraints (domain unzipping), thus lowering the energy barrier for Ca 2ϩ channel opening. Consistent with this hypothesis, single particle analysis of the 3D structure of the RyR2 molecule revealed that the N-terminal and central domains (located in domains 5 and 6 of the so-called clamp region, respectively) are in a close apposition to each other. 4, 5 Recent reports deal with 3 types of knock-in (KI) mice with human CPVT/arrhythmogenic right ventricular cardiomyopathy-associated RyR2 mutations: R4496C, 6 R176Q, 7 and R2474S. 8 Injection of caffeine plus epinephrine or exercise induces ventricular tachycardia (VT) in these mice, indicating that these point mutations can cause lethal arrhythmias. However, the underlying mechanism by which a single mutation causes lethal arrhythmia remains unresolved. We recently reported that in failing hearts, defective interdomain interaction within the RyR2 (aberrant unzipping of the N-terminal/central domain pair and channel activation in an otherwise resting state) causes diastolic Ca 2ϩ leakage and contractile dysfunction. 9 As shown in our previous report, 9 pathological conditions (diastolic Ca 2ϩ leakage and contractile dysfunction) are reproduced in the otherwise normal system by adding DPc10, a central domain peptide (Gly2460-Pro2495) of the RyR2 that interferes with the interaction between the N-terminal and central domains of the RyR2 and causes defective domain unzipping. George et al 10 showed that functional coupling between the cytoplasmic and transmembrane domains of the RyR2 is mediated by the 3722 to 4610 residue region, called the I-domain and that sudden cardiac death (SCD)-linked mutations occurring in the I-domain (N4104K and R4496C) caused channel instability and Ca 2ϩ release dysfunction owing to defective interdomain interactions between the I-domain and the channel domain. These findings suggest that the weakened interdomain interaction at least in these 2 regions of the RyR2 (N-terminal domain/central domain and I-domain/channel domain) is the key mechanism underlying the pathogenesis of CPVT/arrhythmogenic right ventricular cardiomyopathy and heart failure.
Although the domain peptide approach provided important information regarding the underlying mechanism of the RyR2 abnormalities during heart failure and lethal arrhythmia, further in vivo studies with the mutation-linked disease model are required for a straightforward test of the interdomain interaction hypothesis. In the present study, using the KI mouse model with a human CPVT-associated RyR2 mutation, R2474S, we investigated the molecular mechanism by which CPVT is induced by a single point mutation within the RyR2. The data presented here suggested that the introduced mutation, in fact, causes defective interdomain interaction in the RyR2, reduces the threshold of luminal Ca 2ϩ -dependance for channel activation, sensitizes RyR2 to protein kinase (PK)A-dependent phosphorylation, and in turn leads to CPVT.
Methods
An expanded Methods section is available in the Online Data Supplement at http://circres.ahajournals.org.
Animals
This study conformed to the Guide for the Care and Use of Laboratory Animals published by the NIH (NIH Publication No. 85-23, revised 1996) . The care of the animals and the protocols used were in accordance with guidelines established by the Animal Ethics Committee of Yamaguchi University School of Medicine.
Statistics
Paired or unpaired t tests were used for statistical comparisons of data obtained during the 2 different situations, whereas ANOVA with a post hoc Scheffe's test was used for statistical comparison of concentration-dependent data. All data are expressed as meansϮSE. A probability value of Ͻ0.05 was considered statistically significant.
Results

No Appreciable Change in Structural or Functional Characteristics of R2474S/؉ KI Mice During the Resting (Nonactivated) State
In the absence of activation, there was no appreciable difference in the structural or functional features of the hearts between wild-type (WT) and KI mice. Thus, the crosssectional view showed the identical features ( Figure 1A ). Echocardiography revealed no functional difference between WT and KI mice ( Figure 1B ). There was no appreciable change in the KI mice regarding the expression or phosphorylation levels of any of the sarcoplasmic reticulum (SR) proteins examined (Online Figure III ).
Exercise or Drug (Epinephrine and Caffeine) Administration Induced VT in R2474S/؉ KI Mice
In the resting conscious condition, we frequently observed polymorphic ventricular premature contractions in KI mice in response to even very weak stimuli, like light or sound, but not in WT mice (data not shown). Injection of caffeine plus epinephrine (IP) or exercise on a treadmill induced bidirectional or polymorphic VT in KI mice, but not in WT mice (Figure 2A ). The duration of VT in most KI mice was less than 30 seconds ( Figure 2B ).
Seizures Were Not Observed in R2474S/؉ KI Mice
To determine whether seizures occurred in KI mice, as previously reported, 8 we monitored the behavior of mice by video recording for 1 week and assessed their susceptibility to seizures by pharmacological induction (see expanded Methods in the Online Data Supplement). Thus far, we have not observed spontaneous seizures in KI or WT mice. Furthermore, a pharmacological provocation test with 4-aminopyridine and caffeine showed no difference in the latency to the development of generalized tonic-clonic seizures (Online Figure IV ).
Non-standard Abbreviations and Acronyms
Relaxation Phase of Cell Shortening and Ca 2؉ Transient Was Prolonged in the Isoproterenol-Activated R2474S/؉ KI Mice
There was no statistically significant difference in the contour or kinetic parameters of Ca 2ϩ transient and cell shortening at baseline between the WT and KI mice ( Figure 3A and Online Table I ). In response to isoproterenol; however, the time from the peak to 80% decline in cell shortening or Ca 2ϩ transient was prolonged in KI cardiomyocytes, suggesting a delay in the inactivation of Ca 2ϩ release and/or spontaneous Ca 2ϩ release events. Moreover, the SR Ca 2ϩ content, determined by caffeine application, was significantly lower in KI cardiomyocytes than in WT cardiomyocytes, both before and after the addition of isoproterenol ( Figure 3B ). SR Ca 2ϩ -ATPase (SERCA)2 activity could contribute to the slowed decay kinetics of the Ca 2ϩ transient during heart failure. Thus, we next measured the SERCA2-mediated Ca 2ϩ uptake by monitoring the time-dependent change in the intra-SR [Ca 2ϩ ] (Online Figure V) . As shown, there was no appreciable change in the time course of SR Ca 2ϩ uptake.
RyR2 Ca 2؉ Channels of R2474S/؉ KI Cardiomyocytes Were Hypersensitive to Channel Activation by Isoproterenol, PKA Phosphorylation, and Luminal Calcium
In KI cardiomyocytes, Ca 2ϩ spark frequency (SpF) was higher than that in WT cardiomyocytes, both before and after the addition of isoproterenol ( Figure 4A ; for 3D images, see Online Figure VI , A). In the presence of a higher concentration of isoproterenol (100 nmol/L), the frequency of spontaneous Ca 2ϩ waves was much higher in KI cardiomyocytes than in WT cardiomyocytes and the duration of local Ca 2ϩ release provoked by the transmission of the Ca 2ϩ waves was markedly prolonged (Online Figure VII) . In both KI and WT cardiomyocytes, isoproterenol (10 nmol/L) increased the peak amplitude, full width at half maximum (FWHM), and full duration at half maximum (FDHM) (Online Table II ). In KI cardiomyocytes, however, FDHM increased approximately twice as much as in WT cardiomyocytes (Online Table II ). In response to isoproterenol (10 nmol/L), the level of PKA-dependent phosphorylation at Ser2808 of the RyR2 showed a rather modest increase that was slightly less than half of maximum phosphorylation (see Online Figure II ). However, in this case, the extent of the increase was nearly the same in the KI and WT cardiomyocytes ( Figure 4B ). These results suggest that the sensitivity of the channel to both SR content (luminal [Ca 2ϩ ]) and PKA phosphorylation is markedly increased in KI channels. For further analysis of the increased sensitivity of KI channels to PKA phosphorylation and the SR Ca 2ϩ content, we measured the PKA phosphorylation level at Ser2808 of RyR2 after addition of cAMP under the same conditions as the Ca 2ϩ spark assay ([Ca 2ϩ ]ϭ30 nmol/L, buffered by 0.5 mmol/L EGTA). For this purpose, we added the Ca 2ϩ / calmodulin-dependent protein kinase (CaMK)II inhibitor KN-93 (1 mol/L) to inhibit the effect of intrinsic CaMKII on the phosphorylation of the RyR2. We then measured both SpF and SR Ca 2ϩ content in the absence and in the presence of 1 mol/L cAMP in the saponin-permeabilized cardiomyocytes. There was no significant difference in the PKA phosphorylation level at Ser2808 between the KI and WT cardiomyocytes, both in the absence and the presence of cAMP ( Figure 4C ). Because there is marked variation in specificity among antibodies generated against Ser2808, 11 we compared the phosphorylation level at Ser2808 of RyR2 by using another different antibody against Ser2808 (Badrilla, Leeds, UK). There was no significant difference in the PKA phosphorylation level at Ser2808 between KI and WT cardiomyocytes (Online Figure VIII) .
To test the postulated possibility that destabilization of the RyR2 caused by the dissociation of FK506 binding protein 12.6 (FKBP12.6) from the RyR2 is a common pathogenic mechanism underlying heart failure and lethal arrhythmia, 12, 13 we determined the RyR2-bound FKBP12.6 by using a pull-down assay. As shown in Figure 4D , between the WT and KI mice, there was no significant difference in the RyR2-bound FKBP12.6 in the absence or the presence of cAMP (1 mol/L). Figure 5A shows the representative traces of Ca 2ϩ sparks in the presence of various concentrations of cAMP (0.1 to 1 mol/L) (for 3D images of Ca 2ϩ sparks, see Online Figure  VI , B). The dependence of SpF on the SR Ca 2ϩ content is plotted in Figure 5B . To obtain the point at lower SR Ca 2ϩ content, thapsigargin was added to the cardiomyocytes. Then, both Ca 2ϩ sparks and SR Ca 2ϩ content were measured 3, 5, and 10 minutes after the addition of thapsigargin. SpF was higher in KI than in WT cardiomyocytes, although there was a considerable reduction in the SR Ca 2ϩ content in KI cardiomyocytes. As a result, there was a considerable leftshift of the SpF versus SR Ca 2ϩ content plot in the case of KI cardiomyocytes ( Figure 5B ). The effect of cAMP on Ca 2ϩ spark characteristics are summarized in Online Table III . Compared to the WT cardiomyocytes, both the peak amplitude and FWHM decreased whereas FDHM increased in KI cardiomyocytes, suggesting a delay in the inactivation of the RyR2. These results suggest that the threshold of luminal [Ca 2ϩ ] for channel opening decreased considerably owing to the single R2474S CPVT mutation of the RyR2. To assess the maximum capacity of Ca 2ϩ loading of SR, we added tetracaine (1 mmol/L) to inhibit Ca 2ϩ release and then evaluated SR Ca 2ϩ content by caffeine application. After treatment with the Ca 2ϩ release blocker tetracaine (arrows, Online Figure  IX) , the SR Ca 2ϩ content increased and reached nearly the same level (Ϸ4 F/F 0 ) in both WT and KI cardiomyocytes. This suggests that the reduced SR Ca 2ϩ content in the KI cardiomyocytes was not attributable to reduced capacity of Bottom, Summarized data of Ca 2ϩ spark frequency. N indicates the number of cells from 6 to 8 hearts. B, Comparison of PKA-mediated phosphorylation level at Ser2808 of the RyR2 (P-Ser2808-RyR2) in intact KI and WT cardiomyocytes. In the presence of isoproterenol (10 nmol/L), KI and WT cardiomyocytes were incubated in the lysis buffer, and centrifuged. Then, the supernatant fraction containing crude homogenate was used for the phosphorylation assay. C, Comparison of P-Ser2808-RyR2 in KI and WT cardiomyocytes. In the presence of cAMP (1 mol/L), okadaic acid (1 mol/L), and CaMKII inhibitor KN-93 (1 mol/L), KI and WT cardiomyocytes were incubated in the lysis buffer, and centrifuged. Then, the supernatant containing crude homogenate was used for phosphorylation assay. N indicates the number of cell lysate from 3 to 5 heats. D, Effect of cAMP on the RyR2-FKBP12.6 association in WT and KI cardiac homogenates. Top, Representative Western blots of the RyR2 and FKBP12.6 after immunoprecipitation (cf, expanded Methods in the Online Data Supplement). Bottom, Summarized data of the ratio of FKBP12.6 to the RyR2, which was normalized to control condition. Although FK506 dissociated FKBP12.6 from the WT RyR2, shown as positive control, cAMP (1 mol/L) did not dissociate the RyR2-bound FKBP12.6 in WT and KI cardiac homogenates. N indicates the number of SR preparations from 7 to 14 hearts. PKA phosphorylation modulates not only RyR2 function but also SR Ca 2ϩ load dependence of channel activation. Thus, to clarify the direct effect of PKA phosphorylation on RyR2 function, we measured the SpF and SR Ca 2ϩ content in the presence of 0.3 mol/L thapsigargin (inhibitor of SERCA2a activity) ( Figure 5C ). At comparable SR Ca 2ϩ content, PKA phosphorylation increased SpF in KI cardiomyocytes, but not in WT cardiomyocytes. This suggests that PKA-dependent phosphorylation sensitized diastolic SR Ca 2ϩ release, but only in CPVT, and not WT RyR2 channels.
Domain Unzipping Peptide DPc10 Mimics the Phenotype of KI Channels in WT Cardiomyocytes
As shown previously, 9 DPc10 (a peptide corresponding to the 2460 to 2495 region of the central domain) mimics the channel disorder in the CPVT mutant (R2474S) by interfering with the channel-stabilizing interdomain interactions between the N-terminal and central domains (ie, domain unzipping).
To assess the effect of domain unzipping on the dependence of SpF on the SR Ca 2ϩ content, we added DPc10 to the WT saponin-permeabilized cardiomyocytes. Successful incorporation of DPc10 was confirmed by the intracellular fluorescence signal of Alexa fluor 488 -labeled DPc10 (Online Figure X) . DPc10 (50 mol/L, applied externally) induced Ca 2ϩ sparks in WT cardiomyocytes ( Figure 5D , top). Importantly, addition of DPc10 caused a left-shift of the SpF/SR Ca 2ϩ content relationship in WT cardiomyocytes ( Figure 5D , bottom), resulting in the nearly identical SpF/SR Ca 2ϩ profile as that of KI cardiomyocytes ( Figure 5B ). Similar to cAMPtreated KI cardiomyocytes, addition of DPc10 to WT cardiomyocytes prolonged FDHM (21.32Ϯ0.31 ms [nϭ27 cells] to 23.82Ϯ0.54 ms [nϭ48 cells]; PϽ0.01), but decreased the peak (1.74Ϯ0.03 to 1.69Ϯ0.01 arbitrary units; Pϭ0.068) and FWHM (2.05Ϯ0.03 to 2.00Ϯ0.02 m; PϽ0.01). Addition of DPc10 to the (cAMP-treated) KI cardiomyocytes produced no further effect ( Figure 5E ). To assess whether suppression of domain unzipping reversed the left-shift of the SpF/ SR Ca 2ϩ content relationship in KI cardiomyocytes, we added dantrolene, which has corrected aberrant domain unzipping and prevented the development of heart failure. 14 Interestingly, dantrolene shifted back the SpF/ SR Ca 2ϩ content relationship to the right, almost toward the point corresponding to that of WT cardiomyocytes ( Figure 5E ). Dantrolene also prevented the DPc10-induced left-shift of the SpF/SR Ca 2ϩ content relationship in WT cardiomyocytes ( Figure  5D ). Collectively, these findings indicate that the defective interdomain interaction within the RyR2 caused by either point mutation (R2474S) or domain unzipping peptide (DPc10) reduced the threshold of luminal [Ca 2ϩ ] for channel activation, leading to the phenotype of CPVT (hyper-activation of the RyR2 channel). This suggests that as in the case of malignant hyperthermia, correction of the defective interdomain interaction by dantrolene may provide an effective method to treat CPVT.
Luminal [Ca 2؉ ] of SR in Saponin-Permeabilized WT and KI Cardiomyocytes
To confirm the above notion that the level of SR Ca 2ϩ load was decreased in KI cardiomyocytes, we monitored luminal [Ca 2ϩ ] in both cardiomyocytes using fluo-5N as a luminal Ca 2ϩ probe. The average level of free diastolic SR Ca 2ϩ decreased in KI cardiomyocytes, and on caffeineinduced discharge of luminal Ca 2ϩ , the luminal Ca 2ϩ reached the same basal level in both WT and KI cardiomyocytes ( Figure 6 ).
Spectroscopic Evidence That the Interdomain Interaction Is Defective in R2474S/؉ KI Cardiomyocytes
To investigate whether the interdomain interaction was defective in KI mice, we used the fluorescence quench tech-nique that permits spectroscopic monitoring of the state of the interdomain interaction (zipped or unzipped). 15 The methylcoumarin acetamido (MCA) probe that has been attached to the critical domain would be inaccessible to a bulky fluorescence quencher (QSY-BSA conjugate) in a zipped configuration of the interacting domains, whereas it would become accessible to the quencher on unzipping. As in our previous study with DPc10, 9 site-specific intense fluorescence labeling of the RyR2 band was achieved using DPc10 as a carrier (Figure 7A, left lane) , but there was no MCA labeling when DPc10-mut was used as a carrier (middle lane). As shown in the "cold-chase" experiment (right lane), excess unlabeled DPc10 (10 mmol/L) prevented DPc10-mediated MCA labeling. DPc10 increased the slope of the Stern-Volmer plot (K Q ), a measure of the extent of unzipping between the N-terminal (amino acids 1 to 600) and central (amino acids 2000 to 2500) domains in WT SR (Figure 7B, left) . Addition of cAMP (1 mol/L) had no effect (no unzipping) in WT SR (Figure 7B, left) . In contrast, KI SR showed a high K Q value ( Figure 7B, right) . Addition of cAMP (1 mol/L) further increased the K Q , which was comparable with the value of Comparison of the Stern-Volmer plots of the MCA fluorescence quenching data of R2474S/ϩ KI mice with those of WT mice. Note that the K Q increased in the SR vesicles from KI to a similar level as that of DPc10-added WT SR vesicles. The values of K Q are meansϮSE of 5 to 9 experiments using 2 to 3 SR preparations from 20 to 30 mice heart. C, Summarized data of K Q shown in B.
WT SR with added DPc10 (Figure 7B, right) . Addition of DPc10 on the top of cAMP (1 mol/L) produced no further increase in K Q . Interestingly, dantrolene (1 mol/L) partially reversed the K Q that had been increased by cAMP ( Figure  7B, right) . Dantrolene also prevented the DPc10-induced unzipping in WT SR (Figure 7B, left) . These K Q values are summarized in Figure 7C .
Arrhythmogenic Characteristics of the Membrane Potential in R2474S/؉ KI Cardiomyocytes
Because altered membrane potential events represent an important landmark in arrhythmogenesis, 16 we measured m,R 00 -2500) a hegher the WT cardiomyocytes. organized Ca"eased SpF only in KI cardiomyocytes.ICR), membrane potentials of WT and KI cardiomyocytes by recording the di-8-ANEPPS fluorescence while pacing in the presence of 30 nmol/L isoproterenol (Online Figure XI) . WT cardiomyocytes showed no spontaneous after potential ( Figure 8A ) and no spontaneous Ca 2ϩ transient ( Figure 8B ). However, KI cardiomyocytes showed spontaneous Ca 2ϩ transients and spontaneous after potentials in response to isoproterenol (30 nmol/L) when we increased the pacing rate from 1 to 5 Hz (Figure 8A and 8B) . Interestingly, the spontaneous after potentials and Ca 2ϩ transients disappeared in the presence of dantrolene (1 mol/L), which corrected the defective interdomain interaction between the N-terminal and central domains ( Figure 8A and 8B ).
Discussion
Many point mutations have been found in RyR2 in patients with CPVT. Several pieces of biochemical evidence suggest that these mutations cause defective channel gating, leading to diastolic Ca 2ϩ leakage. 17 More direct evidence that a single point mutation in the RyR2 is the primary cause of channel dysfunctions in CPVT patients have been obtained by recent studies with a KI mouse model. 6 -8 A single point mutation (R4496C) introduced in the RyR2 was found to cause bidirectional or polymorphic VT in the KI mice. 6 In isolated cardiomyocytes from the R4496C KI mice, both delayed afterdepolarization (DAD) and triggered activity were induced on stimulation with isoproterenol. 18 A more recent study using the same model 19 showed that a dramatic increase in the Ca 2ϩ sensitivity of the RyR2 channel resulted in the increased frequency of Ca 2ϩ sparks and Ca 2ϩ waves, which was further amplified by either isoproterenol or high pacing rates. Further studies 7,8 confirmed mutation-linked dysfunc- tion of RyR2, namely spontaneous Ca 2ϩ release events and DAD. These studies show a close inter-relationship between the single point mutation, increased Ca 2ϩ sensitivity of the channel gating, and the resulting lethal arrhythmia. However, the underlying mechanism by which a single mutation in such a large molecule causes drastic effects on cardiac function has remained unclear.
Defective Interdomain Interaction Is the Source Mechanism of Mutation-Linked Channel Disorder
The most important new aspect of the present study is the finding that introduction of the R2474S CPVT mutation into the central domain of RyR2 induced a defective interaction between the central domain and the N-terminal domain, as predicted from the "domain switch hypothesis," and this caused channel dysfunction similar to that of CPVT patients in KI mice. The 3 lines of evidence are consistent with this. First, DPc10 (amino acids 2460 to 2495), which contains the mutable R2474 residue and is known to interfere with normal interdomain interaction between the N-terminal and central domains, 9 reproduced the abnormal cellular Ca 2ϩ events seen in the R2474S/ϩ KI mice (eg, increased frequency of Ca 2ϩ sparks) in an otherwise normal system (ie, in cardiomyocytes isolated from WT mice). However, the addition of DPc10 to the (cAMP-treated) R2474S KI cardiomyocytes produced no further effect, suggesting that the defective interdomain interaction (aberrant domain unzipping) had already taken place in the KI cardiomyocytes. Second, The R2474S mutation, introduced into the central domain of RyR2 of KI mice, did produce defective interdomain interaction between the N-terminal and central domain (aberrant domain unzipping), as evidenced by the accessibility of the fluorescent probe MCA attached to the N-terminal domain to a high molecular weight fluorescence quencher QSY7-BSA was considerably higher in the KI RyR2 than the WT RyR2. Finally, dantrolene, which corrects aberrant domain unzipping, did suppress aberrant phenomena characteristic of CPVT KI mice, such as reduced threshold of luminal Ca 2ϩ for channel activation, spontaneous Ca 2ϩ sparks, and DAD.
PKA-Dependent Phosphorylation of the RyR2 at Ser2808 Facilitates Domain Unzipping Only in the CPVT Mutant Ryanodine Receptor
Interesting new finding in the present study is that the threshold of luminal [Ca 2ϩ ] for activation of Ca 2ϩ sparks was much lower in R2474S/ϩ KI mice than in WT mice. In other words, the sensitivity of the RyR2 channel to activation by luminal [Ca 2ϩ ] was increased in R2474S/ϩ KI mice. More importantly, we could reproduce this sensitized channel gating to luminal [Ca 2ϩ ] that is characteristic of the R2474S/ϩ KI mice, in WT cardiomyocytes by adding DPc10 (Figure 5D ). This provides further support for the notion that the aberrant channel gating in R2474S/ϩ KI mice is produced by defective interdomain interaction between the N-terminal and central domains.
This study also showed that the level of PKA-dependent phosphorylation of the RyR2 at Ser2808 was virtually indistinguishable between KI and WT RyR2s ( Figure 4B and 4C ), yet PKA phosphorylation produced a much larger effect in increasing the frequency of Ca 2ϩ sparks (SpF) in the KI cardiomyocytes than the WT myocytes ( Figures 4A and 5A ). This suggests that the CPVT mutation also sensitizes the channel to PKA phosphorylation-dependent activation. In the 3D image of the RyR2, Ser2808, the site of PKA phosphorylation, has been localized in the vicinity of the boundary between the N-terminal (amino acids 1 to 600) and the central domains (amino acids 2000 to 2500). 20 Earlier cryoelectron microscopy single particle study of RyR1 21 also showed that domain 5 (including the N-terminal domain) and domain 6 (including the central domain) at the clamp region are indeed in close apposition to each other in the resting state, whereas these domains become separated in the activated (channelopen) state (eg, in the presence of cAMP and activating Ca 2ϩ ). Thus, it is tempting to suggest that PKA phosphorylation at Ser2808 accelerates domain unzipping in the KI channel, where domain unzipping has already progressed because of a weakened interdomain interaction caused by the CPVT mutation.
A New Molecular Mechanism for CPVT
Although recent studies using KI mouse models have demonstrated that CPVT is caused by mutation-linked dysregulation of intracellular Ca 2ϩ events and membrane potential events (DAD and triggered activity), it is still unclear how a single mutation changes the conformational state of the RyR2, leading to leaky channel. We propose a new molecular mechanism underlying CPVT (Online Figure XII) . In the normal channel, domain-domain interaction between the N-terminal (amino acids 1 to 600) and central (amino acids 2000 to 2500) domains is maintained in a zipped state, and thus, the channel is stabilized, preventing Ca 2ϩ leakage and DAD at a physiological range of SR Ca 2ϩ contents. In the mutant channel, the stabilized interdomain interaction is disrupted, causing aberrant domain unzipping; domain unzipping is further aggravated by the PKA phosphorylation of Ser2808, located at the boundary between the 2 domains at the clamp region. 20 In turn, the threshold of luminal [Ca 2ϩ ] for channel activation is decreased (cf, elsewhere 17 ). Together, this results in SR Ca 2ϩ leakage, DAD, and lethal arrhythmia. It should be noted, however, that DAD-triggered arrhythmia can also be induced by intracellular Ca 2ϩ overload, for example, the toxic arrhythmogenic effects of the cardiac glycosides. 22 In contrast to a previous report, 8 the RyR2-FKBP12.6 link was not disrupted in R2474S/ϩ KI mice. In the present study, the level of PKA-dependent phosphorylation at Ser2808 of the RyR2 showed only a modest increase in response to 1 mol/L cAMP (slightly less than half of maximum phosphorylation; see Online Figure II ). This level of phosphorylation may not have been high enough to dissociate FKBP12.6 from RyR2. Nonetheless, the fact that such a modest increase in the PKA phosphorylation at Ser2808 induced domain unzipping and the resulting Ca 2ϩ leakage in KI mice, suggests that the defective interdomain interaction within the RyR2 is the source mechanism of CPVT and that FKBP dissociation is not a direct cause of defective channel gating in CPVT. As we previously reported, 9 however, it is also true that FKBP dissociation induces domain unzipping, which may account for the destabilized channel gating in heart failure. Thus, either a CPVT-type mutation or FKBP dissociation in heart failure commonly induces domain unzipping as an independent trigger, resulting in aberrant Ca 2ϩ release in diseased hearts.
The reduction in SR Ca 2ϩ content in heart failure may be partly attributable to increased Na ϩ /Ca 2ϩ exchanger function and the increased SR Ca 2ϩ leakage (in addition to reduced SERCA function), causing contractile dysfunction as well as arrhythmia. We previously demonstrated that dantrolene corrects defective interdomain interactions within the RyR2 in failing hearts, inhibits spontaneous Ca 2ϩ leakage, and in turn improves cardiomyocyte function in failing hearts. 14 In this study, we showed that dantrolene was equally effective in the CPVT-type mutated RyR2 as in failing hearts. This indicates that channel dysfunction in CPVT and heart failure are caused by a common mechanism, that is, defective interdomain interaction within the RyR2.
According to a recent report by Lehnart et al, 8 R2474S KI mice, which harbors the same mutation as those used in the present study, exhibited spontaneous generalized tonic-clonic seizures. In our KI mice, however, we did not observe spontaneous tonic-clonic seizures. We have no explanation for this difference. It may be ascribable to differences in the background of the mouse model. In generating the RyR2 KI mice, we used ES cells derived from C57BL/6J mouse (no difference in the background between ES cell line mice and KI mice), but Lehnart et al used those from 129 mice, followed by back-crossing with C57BL/6J mice.
In this, study, we evaluated the phosphorylation status only at Ser2808. However, because ␤-adrenergic stimulation has been reported to activate CaMKII, 11,23 a further investigation is clearly needed to assess the role of other phosphorylation sites (eg, Ser2814 and Ser2030) on CPVT-type channel disorder.
In conclusion, a single point mutation within the RyR2 sensitizes the RyR2 channel to activation by luminal [Ca 2ϩ ] (ie, a decreased threshold of luminal [Ca 2ϩ ] for channel activation), and in turn induces spontaneous Ca 2ϩ sparks and DAD, leading to CPVT. More importantly, this aberrant channel opening is primarily mediated through defective interdomain interaction between the N-terminal (amino acids 1 to 600) and central (amino acids 2000 to 2500) domains.
